GE Healthcare Commits To China’s Basic Health Care
This article was originally published in PharmAsia News
Executive Summary
GE Healthcare announced that it will further strengthen support for basic health care in China's rural areas, promising to launch five new products by 2010 to meet requirements of the market. The firm has given R&D priority to develop high-tech but low-price products since 2006. Items suitable for rural areas such as ultrasonic diagnosis devices, patient monitor systems, EKG and anesthesia facilities have contributed to GE Healthcare's 30 percent marketshare in China and the figure is rising. To align with the health care reform, GE Healthcare has specially mapped out a tier-two market strategy that supplies basic health care products with high performance-price ratios to rural hospitals, making early diagnosis accessible to the rural community. (Click here for more - Chinese Language)
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.